These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Nevirapine--the first non-nucleoside inhibitor of reverse transcriptase in the battle against AIDS]. Wiese E Pharm Unserer Zeit; 1997 Mar; 26(2):99-100. PubMed ID: 9289739 [No Abstract] [Full Text] [Related]
3. Current clinical treatments of AIDS. Murphy EM; Jimenez HR; Smith SM Adv Pharmacol; 2008; 56():27-73. PubMed ID: 18086408 [No Abstract] [Full Text] [Related]
7. [AIDS: the myth of Sisyphus]. Jaubert D Med Trop (Mars); 1999; 59(1):31-2. PubMed ID: 10472577 [No Abstract] [Full Text] [Related]
8. The search for potent, small molecule NNRTIs: A review. Prajapati DG; Ramajayam R; Yadav MR; Giridhar R Bioorg Med Chem; 2009 Aug; 17(16):5744-62. PubMed ID: 19632850 [TBL] [Abstract][Full Text] [Related]
9. Targeting a deadly scrap of genetic code. Cowley G Newsweek; 1996 Dec; 128(23):68-9. PubMed ID: 10162944 [No Abstract] [Full Text] [Related]
10. [Molecular bases in the search for drugs for treating AIDS. Achievements and possible prospects]. Kraevskiĭ AA Mol Biol (Mosk); 1999; 33(3):343-52. PubMed ID: 10519109 [No Abstract] [Full Text] [Related]
12. The end of AIDS? Leland J Newsweek; 1996 Dec; 128(23):64-8, 71, 73. PubMed ID: 10162943 [No Abstract] [Full Text] [Related]
13. Viramune Expanded Access Program begins. AIDS Patient Care STDS; 1996 Jun; 10(3):186. PubMed ID: 11361629 [No Abstract] [Full Text] [Related]
14. Guide to major clinical trials of antiretroviral therapy in human immunodeficiency virus-infected patients: protease inhibitors, non-nucleoside reverse transcriptase inhibitors, and nucleotide reverse transcriptase inhibitors. Tavel JA; Miller KD; Masur H Clin Infect Dis; 1999 Mar; 28(3):643-76. PubMed ID: 10194094 [No Abstract] [Full Text] [Related]
15. [Non-nucleoside reverse transcriptase inhibitors of the human immunodeficiency virus]. Roca B; Simón E Med Clin (Barc); 1998 Nov; 111(17):660-2. PubMed ID: 9881349 [No Abstract] [Full Text] [Related]
16. Designing anti-AIDS drugs targeting the major mechanism of HIV-1 RT resistance to nucleoside analog drugs. Sarafianos SG; Hughes SH; Arnold E Int J Biochem Cell Biol; 2004 Sep; 36(9):1706-15. PubMed ID: 15183339 [TBL] [Abstract][Full Text] [Related]
17. Drug-resistant reverse transcriptase genotyping and phenotyping of B and non-B subtypes (F and A) of human immunodeficiency virus type I found in Brazilian patients failing HAART. Caride E; Brindeiro R; Hertogs K; Larder B; Dehertogh P; Machado E; de Sá CA; Eyer-Silva WA; Sion FS; Passioni LF; Menezes JA; Calazans AR; Tanuri A Virology; 2000 Sep; 275(1):107-15. PubMed ID: 11017792 [TBL] [Abstract][Full Text] [Related]
18. HIV-1 reverse transcriptase mutations found in a drug-experienced patient confer reduced susceptibility to multiple nucleoside reverse transcriptase inhibitors. Fitzgibbon JE; DiCola B; Arnold E; Das K; Sha BE; Pottage JC; Nahass R; Gaur S; John JF Antivir Ther; 2001 Dec; 6(4):231-8. PubMed ID: 11878404 [TBL] [Abstract][Full Text] [Related]
19. Cushing's syndrome mimicking lipodystrophy syndrome in a patient with AIDS. Bates SM; Page KB; Nakielny RA; Talbot MD Int J STD AIDS; 2002 Sep; 13(9):648-9. PubMed ID: 12243135 [No Abstract] [Full Text] [Related]
20. [New fixed once daily combination as nucleoside backbone. Basis for long-term therapy success]. MMW Fortschr Med; 2005 Apr; 147 Spec No 1():66-8. PubMed ID: 16385881 [No Abstract] [Full Text] [Related] [Next] [New Search]